Imatinib-resistant - Globe Thesis

Keyword [Imatinib-resistant] Result: 1 - 20 \| Page: 1 of 2
1.	The Effects Of Calmodulin Antagonist Tetrandrine Citrate On The Growth In Vitro And In Vivo Of Chronic Myeloid Leukemia And Its Mechanisms
2.	The Study Of Trichostatin A On Imatinib Resistant Chronic Myeloid Leukemia Cells
3.	Effects Of Imatinib And Rapamycin On MTOR/S6 Signal Transduction Pathway In CD33~+ Cell And Immunity Of T Cell In CML
4.	The Study Of Monitoring In Imatinib-resistant Chronic Myeloid Leukemia Patients
5.	The Effect Of Arsenic Trioxide On Imatinib-Resistant Cell Lines K562R And KBM5R
6.	Detection Of The BCR-ABL Fusion Gene Levels In Chronic Myeloid Leukemia Patients By Real-time Quantitative RT-PCR And Mutation Analysis In The Imatinib Resistant Patients
7.	The Effects Of Nilotinib, Arsenic Trioxide On Proliferation, Apoptosis And BCR-ABL Gene Expression Of Imatinib-resistant K562 Cells
8.	Growth Inhibition Of Imatinib-resistant K562Cells In Vivo And In Vivo By4-chlorobenzoyl Berbamine And Its Mechanisms
9.	Expression And Clinical Significances Of Axl In Chronic Myeloid Leukemia Treatment With Imatinib
10.	The Effect Of Emodin Derivative On Proliferation Inhibition And Apoptosis Induction In Chronic Myelogenous Leukemia Cell K562and Imatinib-resistant K562/G01
11.	Effect Of Nrf2by SiRNA Inhibits On Chemoresistance In Imatinib-resistant K562/G01Cells
12.	Sirna Interference Nrf2Reversed Resistance Mechanisms Of Imatinib-resistant Cell Lines K562/G01Research
13.	Efficacy Of Nilotinib On Imatinib-Resistant OR-Intolerant Chronic Myeloid Leukemia
14.	Study On Effects Of PHI On Imatinib-resistant K562/G01Cell Line And Mechanisms Of Reversal Of Drug-resistance
15.	Efficacy Of 2nd Generation’s TKI In Treatment Of Imatinib Resistant Or Intolerant Chronic Myelogenous Leukemia
16.	The Change Of ErbB Signaling Pathways In Secondary Imatinib Resistant Gastrointestinal Stromal Tumors
17.	Clinical Observation Of Nilotinib In Patients With Imatinib-resistant Or Intolerant Chronic Myeloid Leukemia
18.	Design,Synthesis And Bioactivity Activity Evaluation Of Novel Selective C-KIT/PDGFR? Dual Inhibitor For The Treatment Of Imatinib-resistant Gastrointestinal Stromal Tumors (GISTs)
19.	The Role Of FoxM1-induced DNA Damage Response In Imatinib-resistant Chronic Myeloid Leukemia And It's Regulatory Mechanisms
20.	Effect Of Homoharringtonine On Proliferation And Apoptosis On Imatinib-resistant Chronic Myelogenous Leukemia Cells And The Relationship With Bcl-6/p53 Pathway
<<First <Prev Next> Last>> Jump to